User: Guest  Login
Less Searchfields
Simple search
Sort by:
and:
More ...

Ankerst, D. P.;Engel, J.
Status of quality of life in breast cancer research before, during and beyond treatment
Expert Review Pharmacoeconomics & Outcomes Research
2006
6
2
Apr
207--214

More ...

Wilson, C. S.;Davidson, G. S.;Martin, S. B.;Andries, E.;Potter, J.;Harvey, R.;Ar, K.;Xu, Y.;Kopecky, K. J.;Ankerst, D. P.;Gundacker, H.;Slovak, M. L.;Mosquera-Caro, M.;Chen, I. M.;Stirewalt, D. L.;Murphy, M.;Schultz, F. A.;Kang, H.;Wang, X.;Radich, J. P.;Appelbaum, F. R.;Atlas, S. R.;Godwin, J.;Willman, C. L.
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Blood
2006
108
2
Jul
685--696

More ...

Petrylak, D. P.;Ankerst, D. P.;Jiang, C. S.;Tangen, C. M.;Hussain, M. H. A.;Lara Jr., P. N.;Jones, J. A.;Taplin, M. E.;Burch, P. A.;Kohli, M.;Benson, M. C.;Small, E. J.;Raghavan, D.;Crawford, E. D.
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16
Journal of the National Cancer Institute
2006
98
8
Apr
516--521

More ...

Thompson, I. M.;Ankerst, D. P.;Chi, C.;Goodman, P. J.;Tangen, C. M.;Lucia, M. S.;Feng, Z.;Parnes, H. L.;Coltman Jr., C. A.
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial
Journal of the National Cancer Institute
2006
98
8
Apr
529--534

More ...

Yildiz-Yesiloglu, A.;Ankerst, D. P.
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings
Progress in Neuro-Psychopharmacology & Biological Psychiatry
2006
30
6
Aug
969--995

More ...

Berry, D. L.;Moinpour, C. M.;Jiang, C. S.;Ankerst, D. P.;Petrylak, D. P.;Vinson, L. V.;Lara, P. N.;Jones, S.;Taplin, M. E.;Burch, P. A.;Hussain, M. H.;Crawford, E. D.
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
Journal of Clinical Oncology
2006
24
18
Jun
2828--2835

More ...

Yildiz-Yesiloglu, A.;Ankerst, D. P.
Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis
Psychiatry Research
2006
147
1
Jun
1--25

More ...

Baillargeon, J.;Platz, E. A.;Rose, D. P.;Pollock, B. H.;Ankerst, D. P.;Haffner, S.;Higgins, B.;Lokshin, A.;Troyer, D.;Hernandez, J.;Lynch, S.;Leach, R. J.;Thompson, I. M.
Obesity, adipokines, and prostate cancer in a prospective population-based study
Cancer Epidemiology, Biomarkers and Prevention
2006
15
7
Jul
1331--1335

More ...

Thompson, I. M.;Chi, C.;Ankerst, D. P.;Goodman, P. J.;Tangen, C. M.;Lippman, S. M.;Lucia, M. S.;Parnes, H. L.;Coltman, C. A.
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
Journal of the National Cancer Institute
2006
98
16
Aug
1128--1133

More ...

Parekh, D. J.;Ankerst, D. P.;Higgins, B. A.;Hernandez, J.;Canby-Hagino, E.;Brand, T.;Troyer, D. A.;Leach, R. J.;Thompson, I. M.
External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population
Urology
2006
68
6
Dec
1152--1155